Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC
Status:
Completed
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test non-inferiority of spectral CT with low contrast agent
and low radiation dose, compare to conventional liver CT in surveillance of hepatocellular
carcinoma (HCC) in high-risk patient.